Empery Asset Management, LP → Annovis Bio, Inc. ANVS

Stake: — Shares: — Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-08-31

DTC 9.59

4,989,785 shares short · +0.5% vs prior

Other Filings by Empery Asset Management, LP

Filed	Form	Issuer	Stake	Shares
2026-09-03	SCHEDULE 13D/A	Empery Digital Inc.	—	4,830,345	view →
2026-08-14	SCHEDULE 13D/A	Empery Digital Inc.	15.76%	4,330,345	view →
2026-01-05	SCHEDULE	Empery Digital Inc. EMPD	8.97%	3,030,345	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →